Cip1/Waf1 cyclin-dependent kinase inhibitor (p21) is inducible by Raf and mitogen-activated protein kinase kinase (MAPKK), but the level of regulation is unknown. We show here by conditional and transient Rasexpression models that Ras induces p21. Induction of p21 in conditionally Ras-expressing cells is posttranscriptional utilizing mitogen-activated protein kinase (MAPK) pathway. Transient, high-level Ras-expression induces transcriptional activation of p21 mediated by a GC-rich region in p21 promoter -83-54 bp relative to the transcription initiation site containing binding sites for Sp1-family transcription factors. Mutation of either Sp1-binding site 2 or 4 in this region decreases the magnitude of induction of promoter activity by Ras, but only the simultaneous mutation of both sites abolishes fully the induction. Electrophoretic mobility shift assays using an oligonucleotide corresponding to Sp1-binding site 2 indicate that both Sp1 and Sp3 transcription factors bind to this region. The results demonstrate that the central cytosolic growth regulator Ras is a potent transcriptional and posttranscriptional inducer of the nuclear growth inhibitor p21.
Introduction
Ras is a central mediator of growth factor-induced cell proliferation and dierentiation functioning through Raf and extracellular signal-regulated kinases (ERKs), constituents of the mitogen-activated protein kinase (MAPK) pathway (reviewed by Hunter, 1997) . Ras is a known mitogen required throughout the G 1 -phase of the cell cycle and is essential for S phase progression of ®broblasts (Dobrowolski et al., 1994) . The expression of activated Ras leads to an increase in cyclin D1 expression, accumulation of Cdk4/cyclin D1 complexes (Winston et al., 1996) , and shortening of the G 1 -phase (Liu et al., 1995) . Cyclin D1 together with its respective Cdks target phosphorylation of retinoblastoma (RB) protein (reviewed by Sherr, 1996) and thus inactivate the G 1 -restriction point control. Expression of dominant negative Ras blocks the activation of cyclin D1 and E in serum-stimulated cells and prevents their entry into S (Leone et al., 1997) . The presence of RB is needed for the arrest of cells by Ras-antibodies or dominant negative Ras (Peeper et al., 1997) .
Despite positively driving the cell cycle and causing cell transformation, Ras arrests the proliferation of primary rat Schwann cells, pheochromocytoma cells, and rodent ®broblasts (Bar-Sagi and Feramisco, 1985; Benito et al., 1991; Franza et al., 1986; Ridley et al., 1988) , and induces cellular senescence of human diploid ®broblasts and primary mouse ®broblasts (Serrano et al., 1997) . These opposing eects are at least partly dependent on cell type and the function of tumor suppressor genes. The absence of negative regulators like p53, p16
INK4a (Serrano et al., 1997) , or RB (Peeper et al., 1997) render the cells subject to cellular transformation by Ras rather than to growth arrest. Similarly, in the absence of Cdk inhibitor (CKI) p21
Cip1/Waf1 (p21) (Missero et al., 1996; Michieli et al., 1996) or presence of co-operative oncogenes such as Myc (Land et al., 1983) , Ras causes transformation. The collaborative eect of oncogenes in cellular transformation is re¯ected in their regulation of cyclin-kinase activities. Ras is incapable of promoting entry of REF52 ®broblasts into S phase, whereas the simultaneous expression of Ras and Myc leads to DNA replication and increased cyclin E/Cdk2-kinase activity. The latter eect is enhanced by a loss of p27 Kip1 in a posttranscriptional manner, while expression of either Myc and Ras alone has no eect on p27 (Leone et al., 1997) .
p21 is a wide-spectrum inhibitor of G 1 and S phase cyclin-Cdk complexes (Xiong et al., 1993) but, on the other hand, functions as an assembly factor for Cdk4/ cyclin D1 complexes . p21 has several cellular binding partners, including GADD45 damage response protein (Kearsey et al., 1995) and PCNA (Chen et al., 1995) . The sequestration of PCNA by p21 from the replication machinery proteins inhibits DNA replication (Flores-Rozas et al., 1994) and interferes with the interaction of PCNA with DNA methyltransferases (Chuang et al., 1997) . The loss of p21 leads to defective damage responses and loss of G 1 and mitotic checkpoint control (Brugarolas et al., 1995; Deng et al., 1995) . The action of p21 is thus implicated not only in cell cycle regulation, but also in control of DNA replication, integrity, and repair.
A major transcriptional regulator of p21 is p53 tumor suppressor gene. The transactivation is mediated by speci®c p53-binding sites in the p21 promoter (ElDeiry et al., 1993) . Other transcriptional activators of p21 include tumor suppressor BRCA-1 , transforming growth factor-b (Datto et al., 1995b) , activin A (Zauberman et al., 1997), cytokines acting through STAT-pathway (Chin et al., 1996) , nerve growth factor (Yan and Zi, 1997) , tumor promoters (Zeng and El-Deiry, 1996) , vitamin D 3 (Liu et al., 1996b) , retinoic acid receptor (Liu et al., 1996a) , glucocorticoids , progesterone (Owen et al., 1998) , Raf (Sewing et al., 1997) , and MAPKK (Liu et al., 1996c) , while Ras-mediated induction of p21 is negatively regulated by Rho (Olson et al., 1998) . Furthermore, growth factors PDGF, FGF, and EGF (Michieli et al., 1994) , as well as tumor suppressor gene WT1 (Englert et al., 1997) induce p21 mRNA levels. Besides transcriptional activation, phorbol ester and vitamin D 3 are demonstrated to induce p21 posttranscriptionally (Russo et al., 1995; Schwaller et al., 1995) . Other posttranscriptional activators of p21 include okadaic acid (Zeng and El-Deiry, 1996) , and diethylmaleate, which acts through the MAPK pathway (Russo et al., 1995) .
Balanced growth is dependent on appropriate action of both growth stimulators and inhibitors, between which continuous cross-talk is necessary. p21 is inducible by Ras, Raf and MAPKK but the level of this regulation is unknown. For this reason, we undertook analysis of p21-regulation by Ras and demonstrate here that Ras induces p21 both transcriptionally and posttranscriptionally. The posttranscriptional induction involves MAPK pathway whereas transcriptional induction is conferred by two Sp1/Sp3 binding sites in the region 783 to 754 relative to the transcription initiation site.
Results

Eects of conditional Ras expression on cell cycle proteins
The eects of c-Ha-ras(Val-12) on cell cycle proteins were studied using inducible Ras expression in NIH3T3 cells. In this model is expressed under the control of lactose promoter imbedded in SV40 Tpromoter (pSVlacOras), the expression of which is controlled by a lactose-repressor expression vector (pHbINLSneo) co-transfected to the cells. The expression of Ras is induced by inactivating the lactose repressor with lactose analog IPTG. NIH3T3 cells were transfected with pSVlacOras and pHbINLSneo and the inducibility of Ras by IPTG was tested by immunoblotting. Three Ras-clones with highest Ras-inducibility (clones ras8, 22, and 30) were chosen for more detailed studies (Figure 1a, upper panel) . Basal Rasexpression was increased in the Ras-clones, but it was still clearly induced by IPTG (Figure 1a , upper panel).
Since Ras is a known growth regulator, we investigated the eects of its conditional expression on cell cycle proteins. The basal levels of p21 were found to be increased in all three clones by immunoblotting analysis (Figure 1a , middle panel). Moreover, induction of Ras expression with IPTG signi®cantly induced p21 expression in the Ras-clones. However, the protein levels of a dominant p21 eector, p53, were unaected ( Figure 1a , lower panel). The kinetics of p21 induction paralleled the induction of Ras being detectable at 6 h and peaking at 16 h (4.7-fold and 5.4-fold induction of Ras and p21, respectively) (Figure 1b) . Similarly to the kinetics of Ras induction, high p21 levels were maintained in the cells for at least 3 days (data not shown).
To gauge whether the observed changes in p21 accompany altered regulation of its cell cycle binding proteins, the levels of Cdk2, 4 and 6, cyclin D1 were analysed in ras8-cells. As shown by immunoblotting, the levels of Cdk2, 4, and 6 were unaected by conditional Ras expression (Figure 2a ), whereas cyclin D1 was upregulated upon Ras expression as demonstrated by immunoblotting of immunoprecipitated lysates with cyclin D1 antibody (Figure 2b) . Further, the ability of p21 to form complexes with its target proteins was assessed by immunoprecipitation using Cdk2 and 4 antibodies followed by p21 immunoblotting. As shown in Figure 2c , the amount of p21 present in both Cdk2 and 4 complexes was increased by Ras (left panel). Furthermore, in cells treated with IPTG more cyclin D1 was bound to Cdk4 despite the unaltered Cdk4 level (Figure 2c, right panel) . However, there was no positive regulation of p27 by Ras either as measured by its ability to complex with Cdk2 or Cdk4 (Figure 2d ) or at the level of total protein ( Figure 2a ).
p21 protein synthesis is increased by conditional Ras expression
The eect of Ras on p21 protein synthesis was studied by metabolic labeling of ras8-cells, incubated either in the presence or absence of IPTG, with [ Cip1/Waf1 by Ras L Kivinen et al 2 and 8). However, chases of the metabolically labeled IPTG-induced ras8-cells followed by immunoprecipitation with anti-p21 antibody, indicated that there was no change in p21 protein half-life (mean of two independent experiments being 2.1 and 2.2 h in control and in IPTG-treated ras8-cells, respectively) ( Figure 3) . The results suggested that p21 induction by conditional Ras expression occurs via increase in p21 protein synthesis.
MAPK kinase inhibitor PD 098059 abolishes p21 induction
To study which Ras-signaling pathways are mediating the p21 regulation, chemicals blocking either tyrosine kinase action (genistein), protein kinase C pathway (bisindolylmaleimide I, chelerythrin, staurosporine), superoxide radicals (N-acetylcysteine), and ®nally, the MEK/ERK kinase pathway (PD 098059) were utilized (Alessi et al., 1995) . Except for the MAPK kinase (MEK) inhibitor, PD 098059, none of the inhibitors was able to modulate p21 induction in Ras-expressing cells (data not shown). A 16-h incubation of ras8-cells with PD 098059 in the presence of IPTG abolished p21 induction in a dosedependent manner suggesting that the Ras-eect is exerted through MEK (Figure 4 , upper panel). This was substantiated by the fact that calyculin A, a phosphatase inhibitor, positively regulated p21 expression, which could not further be potentiated by Ras expression (Figure 4 , lower panel).
p21 mRNA is not signi®cantly induced by conditional Ras expression As p21 is regulated both transcriptionally and posttranscriptionally (Liu et al., 1996c; Macleod et al., 1995; Schwaller et al., 1995; Zeng and El-Deiry, 1996) , we were interested to analyse the level of p21-regulation by Ras. Northern blotting experiments revealed a slight increase in basal expression of p21 mRNA in the Ras-clones as compared to NIH3T3 cells and neo-clones (mean induction of 1.6-fold in Figure 5a ). p21 mRNA was slightly, but not signi®cantly aected by Ras expression (1.2 ± 1.4-fold induction, Figure 5a ). As p21 protein levels were rapidly increased by Ras, a kinetic study was performed incubating clone ras8-cells in the presence of IPTG for 2, 5, 12 and 23 h followed by Northern analysis. Again, induction of p21 mRNA was limited (1.3-fold induction at the highest) ( Figure 5b ). Since MEK1(/2) inhibitor was found to decrease basal levels of p21 protein, as well as abolish p21 induction by conditional Ras expression, we further analysed its eect on p21 mRNA. PD 098059 was unable to reduce p21 mRNA expression in ras8-cells ( Figure 5c ) further suggesting that conditional Ras expression does not convey signi®cant p21 mRNA regulation.
Transcriptional activation of p21 by Ras expression
To investigate possible transcriptional activation of p21 by Ras, we transiently transfected oncogenic Ras (EJ6.6) together with 2.4 kb p21-promoter luciferase construct (p21p) (Datto et al., 1995b) to COS-7 ( Figure  6a ) and NIH3T3 ( Figure 6b ) cells and assayed for the luciferase activity. As compared to controls transfected with pCDneo, Ras increased p21 promoter activity by 6.0-and 7.6-fold in COS-7 and NIH3T3 cells, respectively ( Figure 6a and b). In order to determine the site in p21 promoter conferring Ras-induced transcriptional activation, a series of 5'-deletion constructs based on 2.4 kb p21 promoter were utilized (Datto et al., 1995b) . Deletion of up to 7110 bp relative to the transcription initiation site (Sma) gave similar levels of induction as the full-length promoter construct ( Figure 6a and b, see also Figure 7 ), whereas the induction was lost in a deletion construct containing only 61 bp proximal to the transcription start site (minimal promoter construct, SmaD1) (Figure 6a and b, see also Figure 7 ). These results indicate that Ras is capable of transcriptional activation of p21 through response elements between 7110 to 762 bp in the p21 promoter. However, when 2.4 kb (p21p) or 93 bp (93-S) p21 promoter constructs were transfected to ras8-cells and Ras expression induced by IPTG, the luciferase activity was not signi®cantly induced (1.4-and 1.5-fold by p21p and 93-S respectively, Figure 6c ).
Identi®cation of Ras-responsive elements in the p21 promoter
Human p21 promoter sequence between 7110 and 761 bp from the transcription start site carries three GC-rich Sp1-binding sites (numbered 1 ± 3 in Figure 7) , the middle of which overlaps with a TGF-b responsive element (TbRE, Figure 7 ) (Datto et al., 1995b) . Two additional Sp-1 sites are located close to the TATAbox, between 761 to 750 (Sp1-binding sites 4 and 5, Figure 7 ). To determine which of these elements mediate the Ras-responsiveness, a series of mutant constructs were employed, in which the putative Sp1-binding sites (mut 2 to mut 5, and mut 2.2), TbRE (mut 2, mut 2.2, and mut 2.3) or TATA-box (mut 5) were disrupted by mutating the sequence of ten nucleotides (nt) in each region, except for the constructs mut 2.2 and mut 2.3 which diered only by 2 bp from the wild-type p21 promoter sequence ( Figure 7 ) (Datto et al., 1995b) . COS-7 cells were cotransfected with Ras and the indicated constructs, and luciferase activity was measured. Mutation of Sp1-binding sites 2 or 4 led to a decrease in the luciferase activity (constructs mut 2, mut 4, mut 2.2) as did the mutation of TbRE (mut 2.3), whereas mutations in Sp1-binding site 5, or in TATA-box or its vicinity were without eect (mut 5 and mut 6) ( Figure 7) . Additionally, mutation of Sp1-binding site 3 (mut 3) decreased somewhat the level of Ras-inducibility. All mutant constructs decreased the basal luciferase activity, but mut 2 elicited the strongest eect.
Since none of the GC-rich regions alone could totally abolish the transcriptional induction by Ras, we generated, using a PCR-based approach, p21 promoter luciferase constructs harboring mutant sequences simultaneously in two or three of the Sp1-binding sites in regions 783 to 754 bp (mut 2+3, mut 3+4, mut 2+4 and mut 2+3+4) (Figure 7 ). When cotransfected to COS-7 cells with the Ras-expression vector, constructs with mutations in the Sp1-binding sites 2 and 4 showed loss of activation of the luciferase transcription by Ras (mut 2+4 and mut 2+3+4) Figure 4 MEK inhibition abolishes Ras-inducible p21 expression. Ras8-cells were cultured in the presence (+) of absence (7) of IPTG and PD 098059 (40, 60 and 80 mM), or calyculin A (1.5 nM) for 16 h followed by analysis of cell lysates by p21 immunoblotting Figure 5 Eects of conditional Ras expression on p21 mRNA levels. (a) Neo and Ras clones were treated with IPTG (10 mM) for 72 h, poly(A) + mRNA was isolated and Northern analyses were carried out using 32 P-labeled mouse p21 and GAPDH cDNAs as probes. (b) Ras8-cells were incubated with 10 mM IPTG for indicated times followed by Northern analyses. The fold induction as compared to non-IPTG treated cells is shown below. (c) Ras8-cells were incubated with 10 mM IPTG in the presence or absence of PD 098059 (80 mM) for 12 h followed by Northern blotting. The fold induction as compared to untreated control cells (lane 1) is shown. Quantitations were carried out by Phosphoimager analyser and corrected to the GAPDH levels (Figure 7) . In contrast, the induction of the luciferase activity of mut 2+3 and mut 3+4 by Ras was similar to induction with constructs mut 2 and mut 4, respectively, indicating minor signi®cance of the Sp1-binding site 3 in the Ras-eect.
Role of Sp1 and Sp3 transcription factors in transcriptional activation of p21 by Ras
To elucidate the role of two closely related transcription factors Sp1 and Sp3 in transcriptional activation of p21, we analysed by gel mobility shift assays (EMSAs) DNA-protein complexes induced by Ras. The binding reactions were carried out using wild-type (wt) or mutated (mut) oligonucleotides corresponding to the Sp1-binding site 2. In Rastransfected NIH3T3 cells three DNA-protein complexes speci®c for wt probe were observed (I, II, and III, Figure 8a ), which were eectively competed with wild-type ( Figure 8a , lanes 2 ± 5) but not with mutant cold oligonucleotide (Figure 8a , lanes 6 ± 8) and were not observed using mutant probe (Figure 8a , lanes 9 ± 11). An additional band (Figure 8a , denoted by *) was seen in reactions with both wt and mutant probes and was competed with cold wt as well as mutant oligonucleotides. The same speci®c and unspeci®c bands were seen also in Ras-transfected COS-7 cells (data not shown).
To study if any of the DNA-protein complexes contain Sp1 or Sp3 transcription factors, we incubated nuclear extracts of Ras-transfected COS-7 or NIH3T3 cells with anti-Sp1 and anti-Sp3 antibodies followed by addition of labeled wt or mutant probe. In COS-7 cells addition of Sp1 antibody led to a supershift of the complex I (Figure 8b , lanes 4 ± 5, double arrow on the right) and Sp3 antibody to a shift of complex II and III (Figure 8b , lanes 6 ± 7, arrow on the right) indicating the presence of Sp1 and Sp3 proteins in these complexes. However, though similar DNA-protein complexes were observed in NIH3T3 cells (I, II, and III, Figure 8c , lanes 2 ± 3), and Sp3 antibody shifted complexes II and III (lanes 6 ± 7, arrow on the right), Sp1 antibody was without eect on complex I (lanes 4 ± 5). Neither Sp1 nor Sp3 antibody aected the unspeci®c bands seen with mutant probe (Figure 8b and c, lanes 8 ± 11). As compared to control vector transfected cells, Ras expression did not have any eect on DNA-binding anity of Sp1 or Sp3 transcription factors. The results thus indicate that depending on cellular context, either both Sp1 and Sp3 or Sp3 alone bind to region in question.
Discussion
In recent studies, Ras as well as Raf/MAPK cascade has been implicated in the regulation of p21. Oncogenic Ras causes cell senescence via accumulation of growth regulators p16, p53 and p21 in primary hunan and rodent cells (Serrano et al., 1997) . In primary rat Schwann cells, activation of Raf, a Ras- eector, leads to G 1 growth arrest, induction of p21 in a p53-dependent manner and inactivation of Cdk/ cyclin complexes . Consistently, moderate Raf-expression leads to activation of Cdk/ cyclin activity and cell cycle progression whereas high levels of Raf cause p53-independent p21 induction and cell cycle arrest (Sewing et al., 1997; Woods et al., 1997) . Our data con®rm the earlier observations of Ras inducing p21 (Serrano et al., 1997; Sewing et al., 1997; Olson et al., 1998) , but extend the p53-independent transcriptional and posttranscriptional components of Ras-regulation of p21. In our study, the eect of conditional Ras on p21 protein level is rapid, taking place within 6 h after Ras expression has been turned on. In ras8-cells, however, there was no signi®cant change in p21 mRNA nor was there transcriptional regulation of p21 by Ras. Metabolic labeling of cells showed increased synthesis of p21 protein without a change in p21 protein stability, implying to enhanced translation as a basis of p21 induction by conditional Ras expression. Providing further support for posttranscriptional regulation of p21 in conditionally Rasexpressing cells, p21 mRNA levels were not aected by MEK inhibitor (Figure 5c ), although p21 induction at protein level was abolished (Figure 4 ). Yet, there was a marked induction of p21 promoter activity in COS-7 and NIH3T3 cells transfected with Ras oncogene. It thus appears that Ras expression accomplished in the transient assays is able to transcriptionally induce p21 expression. However, in Ras-expressing cells in which a higher basal level of Ras is maintained constitutively, the transcriptional component upon additional Ras expression is attenuated or absent. Transcriptional induction of p21 by Ras may thus depend on the level of Ras-expression, which after reaching a certain threshold level, switches to posttranscriptional regulation of p21. Our data suggests the presence of both transcriptional and posttranscriptional components in the Ras-regulation of p21 that may be determined by the level of Ras expression. p53 is a potent transcriptional activator of p21 expression, but also p53 independent events including stimulation with growth factors or tumor promoters (Datto et al., 1995a; Michieli et al., 1994; Schwaller et al., 1995; Zeng and El-Deiry, 1996) , expression of tumor suppressors (Englert et al., 1997; Somasundaram et al., 1997) or Raf (Woods et al., 1997) regulate p21. As shown in Figure 1a , upon Ras-expression p53 is not upregulated. Furthermore, the induction of p21 promoter activity with deleted p53-binding sites suggests p53-independent regulation of p21 by Ras (Figure 6a and b) . The observations that conditional Ras expression induces p21 in ras8-cells without aecting the DNA-binding activity of p53, and that Ras induces the expression of p21 in p53 mutant HaCaT cells, also suggest that p21 regulation by Ras is elicited by means other than through p53 (data not shown). MAPK kinase (MEK) expression transcriptionally enhances p21 (Liu et al., 1996c) . The involvement of MEK pathway in p21 induction by Ras is also suggested here by inhibition of the Raseect with speci®c MEK inhibitor in ras8-cells (Figure  4 ), indicating that Ras and MEK act in the same pathway leading to posttranscriptional p21 induction. p21 induction by Ras is shown to be also under negative control by Rho (Olson et al., 1998) . Suppression of Rho-activity allows Ras-mediated p21 induction and leads to growth arrest, whereas high Rho-activity forces cell cycle entry. Rho-regulation of p21 expression involves at least a transcriptional component (Olson et al., 1998) .
Ras has been previously linked to regulation of cell cycle machinery proteins, especially that of cyclin D1 (Arber et al., 1996; Liu et al., 1995) . The expression of activated Ras leads to an increase in cyclin D1 and concomitant accumulation of Cdk4/cyclin D1 complexes (Winston et al., 1996) . However, the complexes are inactive and fail to stimulate the entry of the cells into S phase in the absence of growth factors due to increased binding of p27 CKI to the complex. Upon exposure to growth factors the total level of p27 and its binding to Cdk4/cyclin D1 complexes decreases and P-labeled wild-type (wt) or mutant (mut) oligonucleotide containing the Sp1-binding site 2 of p21 promoter was used in binding reactions with 5 mg (COS-7 cells) or 10 mg (NIH3T3 cells) of nuclear extract. Antibodies (1 mg) against Sp1 and Sp3, or excess cold wild type or mutant oligonucleotides were added as indicated. (a) EMSA assay demonstrating speci®c DNA-protein complexes. EMSA reactions were performed using Ras-transfected NIH3T3 cells and wild type (lanes 2 ± 8) or mutant (lanes 9 ± 11) labeled p21 oligonucleotide probe with increasing amounts of cold wild type (lanes 3 ± 5 and 10) or mutant oligonucleotides (lanes 6 ± 8 and 11) as competitor. (b and c) Identi®cation of DNA-protein complexes containing Sp1 and Sp3 transcription factors. Nuclear extracts of Ras-transfected COS-7 (b) or NIH3T3 cells (c) were used in gel shift assay with wild type (lanes 2 ± 7) or mutant (lanes 8 ± 11) p21 promoter oligonucleotide in the presence of 1 mg of anti-Sp1 (lanes 4 ± 5 and 10) or anti-Sp3 (lanes 6 ± 7 and 11) antibodies as indicated. Arrows on the left identify DNAprotein complexes speci®c for wild type p21 probe (I, II and III); *, an unspeci®c DNA-protein complex; lane 1; free wt probe. Arrow and double arrow on the right, supershift with anti-Sp3 and anti-Sp1 antibodies, respectively
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Cip1/Waf1 by Ras L Kivinen et al the cells traverse to S phase (Winston et al., 1996) . Two recent studies show that dominant negative Ras prevents initiation of DNA synthesis as late as 2 h before S phase because of failure either to reduce p27 levels (Takuwa and Takuwa, 1997) or to cause cyclin D1 induction and p27 reduction which normally take place together with a shift of p27 from Cdk2/cyclin E to Cdk4/cyclin D complexes (Aktas et al., 1997) . In our experiments as well, conditional Ras expression increased cyclin D1 protein level and its binding to Cdk4 complexes. However, although Ras expression increased p21 in Cdk2 and Cdk4 complexes, the level of p27 was unaltered by Ras in the exponentially growing cells, nor was there any change in its ability to form complexes with Cdk2 or 4. These results are concordant with earlier data that Ras alone is unable to aect p27 levels, but that joint expression of Ras and Myc, or additional growth factor stimulation is needed for this eect (Leone et al., 1997; Winston et al., 1996) . Transcriptional activators of p21 converge their action through several transcription factor recognition elements in p21 promoter. Besides p53, transcription factor Ap-2 (Zeng et al., 1997), E2F-1/DP-1 complex (Hiyama et al., 1997) , E2A (Prabhu et al., 1997) , an ets-oncogene related E1AF (Funaoka et al., 1997) , C/EBP , RAR (Liu et al., 1996a) , VDR (Liu et al., 1996b) , STATs (Chin et al., 1996) , and Sp1 family (Biggs et al., 1996; Li et al., 1998; Owen et al., 1998; Prowse et al., 1997; Yan and Zi, 1997) are known to stimulate p21 promoter activity. Our results show that Ras induces p21 transcriptionally and that the Ras-responsive region in p21 promoter spans a short region downstream of the nucleotide 7110 relative to the transcription start site. This promoter area is involved in Ras-regulation both in NIH3T3 and COS-7 cells stressing its importance in Ras-regulation regardless of species or cell type. With the use of more detailed mutant constructs, we mapped the Ras-responsive region to the Sp1-binding sites 2 and 4 in the promoter area 783 to 754. This GC-rich region has been ascribed to contain the TGF-b regulatory region (TGF-b responsive element, TbRE) (Datto et al., 1995b) , and it mediates also the regulation of p21 by NGF (Yan and Zi, 1997) and progesterone (Owen et al., 1998) , and overlaps the region implicated in induction of p21 in keratinocytes by calcium (Prowse et al., 1997) , and in U937 cells by okadaic acid and phorbol ester (Biggs et al., 1996) . However, the site is distinct from that used in BRCA-1-mediated induction of p21 . Similarly, STAT recognition sites, for instance, lie outside the Ras-responsive elements identi®ed here (Chin et al., 1996) . Although serum and many growth factors activate p21 expression, transcriptional induction seen here is unlikely to occur via Ras-activated autocrine loop, since in NIH3T3 cells neither PDGF, FGF-2 nor TGF-b1 were able to activate p21 transcription via the Sp1 elements (data not shown). Further, serum-responsive elements are known to locate between 72581 and 71871 bp in p21 promoter, located far upstream of the Sp1 sequences (Macleod et al., 1995) .
The simultaneous mutation of the Sp1-binding sites 2 and 4 abolished the transcriptional activation of p21 by Ras. However, the activation was absent also in construct SmaDI containing the Sp1-binding site 4. This suggests that intact Sp1-binding site 2 (or TbRE) is required for the function of the Sp1-binding site 4, indicating a critical role for interactions between transcription factors acting in dierent regions for full promoter activity. Similarly, induction of p21 during keratinocyte dierentiation or by progesterone is dependent on spacing of the promoter elements. Insertions between responsive elements or placing of the responsive elements too close to the transcription initiation site abolish the transcriptional activation of p21 (Owen et al., 1998; Prowse et al., 1997) . Here, a mutant construct aecting the TbRE but not eliminating any of the Sp1-binding sites (mut 2.3) (Datto et al., 1995b) , showed a weaker induction of luciferase activity by Ras similarly to the mutants aecting the Sp1-binding site 2 and TbRE simultaneously (mut 2 and mut 2.2). This could refer to the relevance of TbRE as well as the Sp1-binding site 2 in the Ras eect. Binding of Sp1 and Sp3 transcription factors to this region is characterized in this and other studies (Datto et al., 1995b) , but the possibility of other unidenti®ed proteins binding to the same region and aecting the transcription cannot be excluded.
Sp1 transcription factors have been regarded as house-keeping transcription factors. Recently, however, the Sp1 family has been implicated in the induction of p21 by TGF-b (Datto et al., 1995b; Li et al., 1998) , okadaic acid and phorbol esters (Biggs et al., 1996) , NGF (Yan and Zi, 1997) , and progesterone (Owen et al., 1998) , as well as in dierentiation of keratinocytes (Prowse et al., 1997) . Our studies demonstrated the binding of Sp1 and Sp3 transcription factors to the Sp1 binding site 2 in p21 promoter. The signi®cance of other unidenti®ed proteins binding to this region is, however, elusive, and binding may show cell type dierences as demonstrated by the absence of Sp1-DNA complexes in NIH3T3 cells. The DNA-binding of Sp1 and Sp3 was not aected by Ras, and was unaltered also in p21 induction by TGF-b or NGF (Datto et al., 1995b; Yan and Zi, 1997) . This indicates that the transactivation function of these factors is enhanced by mechanisms other than regulation of Sp1 and Sp3 protein level or DNAbinding activity. Taken together, these results suggest that p21 kinase inhibitor is an important eector of Ras cell cycle modulation, and that two close Sp1-binding sites are required for full induction of p21 promoter activity by Ras.
Materials and methods
Cells and cell culture
Mouse NIH3T3 ®broblasts (ATCC CRL 1658) were cultured in D-MEM containing 10% newborn calf serum (NBCS, Gibco±BRL), and COS-7 cells in D-MEM containing 10% fetal calf serum (FCS, Gibco±BRL). Conditionally Ras expressing NIH3T3 cells were established by transfection of the cells by lipofection (Lipofectamine, Gibco±BRL) with plasmids pSVlacOras and pHbINLSneo (Liu et al., 1992) or pHbINLSneo alone (Kivinen et al., 1996) . The selection of the clones after transfection is described earlier (Kivinen et al., 1996) . Clones used in the experiments were NIH3T3
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Cip1/Waf1 by Ras L Kivinen et al lacIneo1 and 4 (neo 1 and neo 4), NIH3T3 lacOras8, 22, and 30 (ras8, ras22, and ras30, respectively). NIH3T3-transfectants were maintained in D-MEM containing 10% NBCS supplemented with 0.4 mg/ml G418. Ras expression was induced by addition of 10 mM lactose analog isopropyl b-Dthiogalactoside (IPTG, Promega).
Immunoblotting analyses
Cell lysates for immunoblotting analyses were prepared as described previously (Kivinen et al., 1993) . Protein concentrations were determined by Bio-Rad D C protein assay, and 200 mg of protein was electrophoretically resolved in 12.5% sodiumdodecyl sulphate-polyacrylamide gel (SDS ± PAGE) and transferred to Immobilon P 1 membranes (Millipore). Equal loading was veri®ed by Coomassie Brilliant BlueR-staining of the gels. Mouse p21 was detected with anti-p21 antibody (13436E, Pharmingen), and mouse p53 with anti-p53 antibody (Pab240, Pharmingen). Anti-Ras antibody (Ab-1) was from Oncogene Science and anti-p27 antibody (kip1) from Transduction Laboratories. The following antibodies were obtained from Santa Cruz Biotechnology: anti-Cdk2 (M2), anti-Cdk4 (C-22), anti-Cdk6 (C-21) and anti-cyclin D1 antibody (H-295). Peroxidase conjugated anti-mouse or anti-rabbit IgG antibodies (Dako, Denmark) were used as conjugated with the exception of p53, Ras, and p27, which were detected with biotinylated rabbit anti-mouse IgG (Dako) and peroxidase-conjugated streptavidin (Dako), with the ®nal detection step by chemiluminescence (ECL, Amersham). The signals were quantitated using Bio-Rad Fluor-S TM MultiImager Program MultiAnalyst Version 1.0.1.
Immunoprecipitation
For analysis of protein synthesis and stability cells were pulse-labeled with 125 mCi/ml of 35 S-labeled methionine/ cysteine (Promix, Amersham) for 6 h in culture medium free of methionine and cysteine. Thereafter the label was washed o and the cells were incubated in culture medium followed by immunoprecipitation. For immunoprecipitation cells were washed twice with TBS (25 mM Tris/HCl pH 8.0, 150 mM NaCl) and lysed with 50 mM Tris/HCl pH 7.5 containing 150 mM NaCl, 0.5% NP-40, 50 mM NaF, 1 mM Na 3 VO 4 , 1 mM phenylmethyl sulfonyl¯uoride, 1 mM dithiothreitol, and 100 mg/ml each leupeptin (Sigma), soybean trypsin inhibitor (Sigma) and E64 (Sigma). Samples containing equal amounts of protein were precleared with GammaBind 
Isolation of poly(A)
+ mRNA and Northern analyses were carried out as before (Kivinen et al., 1996) . Mouse p21 cDNA used as a probe was obtained from B Vogelstein, Johns Hopkins University. Hybridizations were carried out in 50% formamide at 428C. As a control for RNA loading the ®lters were probed with 32 P-labeled glyceraldehydephosphate dehydrogenease (GAPDH) cDNA and quantitated by PhosphoImager analyser. p21 promoter assays COS-7 and NIH3T3 cells were transfected by calcium phosphate precipitation (Graham and van der Eb, 1973) with Ras-expression vector (EJ6.6) (MaÈ kelaÈ et al., 1992) together with human p21 promoter constructs subcloned into pGL2 luciferase reporter vector (Datto et al., 1995b) . Either b-galactosidase expression vector (CMV-b-gal) or Renilla luciferase control vector (pRL-TK, Promega) was included in transfections as a control for transfection eciencies. After a 45-h incubation, cell lysates were prepared and luciferase reporter activities measured using Luciferase Assay System (Promega) by luminometer (DCR-1, Digene Diagnostics). In the case of conditionally Ras-expressing NIH3T3 cells, Rasexpression was induced 16 h after the transfection with p21 promoter constructs by adding 10 mM IPTG and incubating the cells for additional 24 h, after which the luciferase activity was determined.
Deleted p21 promoter constructs (see Figure 6 ) and p21 promoter constructs containing mutations of two (mut 2.2 and mut 2.3) or ten nucleotides (mut 2 to 6) (see Figure 7) are described (Datto et al., 1995b) . p21 promoter constructs containing two or three mutated Sp1-binding sites [mut 2+3; TATCTAGAAC CTCTAGAAAT (783 to 764), mut 3+4; CTCTAGAAAT ATCTAGACAT (773 to 754), mut 2+4; TATCTAGAAC TGAGGCGGGC ATCTAGACAT (783 to 754), and mut 2+3+4; TATCTAGAAC CTCTA-GAAAT ATCTAGACAT (783 to 754)] were generated using one mutated Sp1-binding site containing construct (mut 2, mut3, or mut4) as a template in two successive PCRreactions with appropriate primers. The PCR-products were veri®ed by sequencing and cloned into vector 93-S (Datto et al., 1995b) .
Electrophoretic gel mobility shift assays
NIH3T3 and COS-7 cells were transfected with neomycin resistance gene (pCDneo) or Ras-expression vector (EJ6.6), and nuclear extracts were prepared 45 h after transfection as described (Andrews and Faller, 1991) . In binding reactions, 1.2 ng of annealed and 32 P-endlabeled wild-type Sp1-binding site 2 (786 to 770 in p21 promoter) oligonucleotide (ATTCGGTCCCGCCTCCTTGAGAGC) or mutant oligonucleotide (ATTCGGTCCCGGATCCTTGAGAGC) were incubated with 5 mg (COS-7 cells) or 10 mg (NIH3T3 cells) of nuclear extracts in 10 ml of 26binding buer (HaapajaÈ rvi et al., 1997; PitkaÈ nen et al., 1998) . Anti-Sp1 (1C6) and antiSp3 (D-20) antibodies were from Santa Cruz Biotechnology. Binding reactions in the presence of antibodies or competing cold oligonucleotides were incubated at room temperature for 10 min, after which 1.2 ng labeled probe was added, and the reactions were continued for additional 30 min at 48C. Reaction products were resolved in 4.5% nondenaturing polyacrylamide gel with 5% glycerol in 0.56TBE buer at 48C. The gel was dried and analysed by autoradiography.
Chemicals
PD 098059 and calyculin A were from Calbiochem.
